Triggers of Full-length Tau Aggregation: a Role for Partially Folded Intermediates
Overview
Affiliations
Alzheimer's disease is characterized in part by the accumulation of full-length tau proteins into intracellular filamentous inclusions. To clarify the events that trigger lesion formation, the aggregation of recombinant full-length four-repeat tau (htau40) was examined in vitro under near-physiological conditions using transmission electron microscopy and spectroscopy methods. In the absence of exogenous inducers, tau protein behaved as an assembly-incompetent monomer with little tertiary structure. The addition of anionic inducers led to fibrillization with nucleation-dependent kinetics. On the basis of circular dichroism spectroscopy and reactivity with thioflavin S and 8-anilino-1-naphthalenesulfonic acid fluorescent probes, the inducer stabilized a monomeric species with the folding characteristics of a premolten globule state. Planar aromatic dyes capable of binding the intermediate state with high affinity were also capable of triggering fibrillization in the absence of other inducers. Dye-mediated aggregation was characterized by concentration-dependent decreases in lag time, indicating increased nucleation rates, and submicromolar critical concentrations, indicating a final equilibrium that favored the filamentous state. The data suggest that the rate-limiting barrier for filament formation from full-length tau is conformational and that the aggregation reaction is triggered by environmental conditions that stabilize assembly-competent conformations.
The role of biomolecular condensates in protein aggregation.
Visser B, Lipinski W, Spruijt E Nat Rev Chem. 2024; 8(9):686-700.
PMID: 39134696 DOI: 10.1038/s41570-024-00635-w.
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.
Zheng H, Sun H, Cai Q, Tai H Int J Mol Sci. 2024; 25(9).
PMID: 38732197 PMC: 11084794. DOI: 10.3390/ijms25094969.
Quantification of Methylation and Phosphorylation Stoichiometry.
Ayoub C, Moore K, Kuret J Methods Mol Biol. 2024; 2754:221-235.
PMID: 38512670 DOI: 10.1007/978-1-0716-3629-9_13.
Malyshka D, Jimenez-Harrison D, Kuret J Methods Mol Biol. 2024; 2754:117-129.
PMID: 38512664 DOI: 10.1007/978-1-0716-3629-9_7.
Arar S, Haque M, Bhatt N, Zhao Y, Kayed R ACS Chem Neurosci. 2024; 15(7):1366-1377.
PMID: 38503425 PMC: 10995947. DOI: 10.1021/acschemneuro.3c00614.